Vascular Solutions (VASC) Tops Q2 EPS by 3c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Piper Jaffray Raises Price Target on Vascular Solutions (VASC) to $49 Following 2Q Beat
July 26, 2016 8:07 AM EDTPiper Jaffray reiterated an Overweight rating on Vascular Solutions (NASDAQ: VASC), and raised the price target to $49.00 (from $45.00), following the company's 2Q earnings report. VASC reported revenue of $41.2M, slightly ahead of the consensus of $41.1M. Adjusted EPS was also ahead of consensus coming in at $0.33 compared to $0.30. Management was very upbeat regarding the... More
